Back
Exponent, Inc. 10K Form
Buy
52
EXPO
Exponent, Inc.
Last Price:
$70.08
Seasonality Move:
3.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-03 | 10Q | EXPO/Exponent, Inc. Quarterly |
| 2023-11-03 | 10Q | EXPO/Exponent, Inc. Quarterly |
| 2023-08-07 | 10Q | EXPO/Exponent, Inc. Quarterly |
| 2023-05-05 | 10Q | EXPO/Exponent, Inc. Quarterly |
| 2022-11-04 | 10Q | EXPO/Exponent, Inc. Quarterly |
| 2022-08-05 | 10Q | EXPO/Exponent, Inc. Quarterly |
Receive EXPO News And Ratings
See the #1 stock for the next 7 days that we like better than EXPO
EXPO Financial Statistics
Sales & Book Value
| Annual Sales: | $582M |
|---|---|
| Cash Flow: | $30M |
| Price / Cash Flow: | 29.68 |
| Annual Sales: | $8.07 |
| Price / Book: | 8.69 |
Profitability
| EPS (TTM): | 2.06960 |
|---|---|
| Net Income (TTM): | $106M |
| Gross Margin: | $145.3M |
| Return on Equity: | 25.44% |
| Return on Assets: | 13.69% |
Exponent, Inc. Earnings Forecast
Key Exponent, Inc. Financial Ratios
-
The Gross Profit Margin over the past 36 years for EXPO is 24.97%.
-
The Selling, General & Administrative Expenses for EXPO have been equal to 4.38% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of EXPO is 18.21% of Total Revenues.
-
Per Share Earnings over the last 36 years have been positive in 24 years.
Exponent, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Professional Services |
| Sector: | Industrials |
| Current Symbol: | EXPO |
| CUSIP: | 30214U |
| Website: | exponent.com |
Debt
| Debt-to-Equity Ratio: | 0.21 |
|---|---|
| Current Ratio: | 2.4 |
| Quick Ratio: | 2.27 |
Price-to-Earnings
| Trailing P/E Ratio: | 33.89 |
|---|---|
| Forward P/E Ratio: | 25.87 |
EXPO Technical Analysis vs Fundamental Analysis
Buy
52
Exponent, Inc. (EXPO)
is a Buy
Is Exponent, Inc. a Buy or a Sell?
-
Exponent, Inc. stock is rated a BuyThe current Exponent, Inc. [EXPO] share price is $70.16. The Score for EXPO is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.